Objective: To examine the relationship between selenium nutritional status and intermediates of human immunodeficiency virus (HIV)-1 transmission. Design: Prospective cohort study. Setting: A study clinic at Muhimbili National Hospital, Dar es Salaam, Tanzania. Subjects: A total of 340 HIV-1-infected pregnant women with gestational ages 12-27 weeks. Methods: Women's plasma selenium concentrations were determined at enrollment and modeled as tertiles (tertile 1: o114 mg/l (reference); tertile 2: 114-131 mg/l; tertile 3: 4131 mg/l). Cervicovaginal lavage specimens were obtained at 36 weeks of gestation to determine HIV-1 RNA and interleukin-1b (IL-1b) levels. In subgroup analyses, 123 women with genital tract infections at enrollment were excluded. Results: Plasma selenium concentrations X114 mg/l were related to increased risk of lower-genital shedding of HIV-1 RNA. Excluding women with genital tract infections strengthened the associations (relative risk (RR) tertile 2: 1.46, 95% confidence interval (CI) ¼ 1.10, 1.92; RR tertile 3: 1.39, 95% CI ¼ 1.05, 1.84). There was evidence for an association between plasma selenium concentrations X114 mg/l and increased HIV-1 RNA levels among the entire cohort and after excluding women with genital tract infections. There was no association between plasma selenium and IL-1b concentrations. Conclusions: High selenium status may lead to increased risk of genital HIV-1 shedding, but data from other studies indicate that the evidence is mixed. Results from ongoing selenium trials are awaited to clarify the impact of selenium on HIV-1-related transmission endpoints.
Introduction
Approximately 38.0 million adults and 2.3 million children are currently infected with human immunodeficiency virus (HIV) worldwide (UNAIDS, 2005) . Heterosexual transmission and mother-to-child transmission (MTCT) are the primary routes of infection for adults and children, respectively. Shedding of HIV-1 in the female genital tract (Montano et al., 2003; Tuomala et al., 2003) and levels of interleukin-1b (IL-1b) (Fichorova et al., 2001) are mediators of these routes of transmission, and identifying their determinants may help in the search of effective intervention strategies to lower HIV-1 transmission rates.
In a trial on the effects of multivitamin supplements on pregnancy outcomes among HIV-1-infected Tanzanian women, supplements containing vitamins B, C and E were beneficial for pregnancy outcomes (Fawzi et al., 1998) and slowing HIV-1 disease progression (Fawzi et al., 2004b) , but had no effect on genital HIV-1 shedding and intrapartum MTCT of HIV-1 (Fawzi et al., 2000 (Fawzi et al., , 2004a . In contrast, a clinical trial among nonpregnant HIV-1-infected women in Kenya showed that women using the same multivitamin supplement plus selenium had an increased risk of genital tract viral shedding . This finding suggests that selenium supplementation may have adverse effects among HIV-1-infected women.
To date, there are no direct clinical trial data on the effect of selenium supplementation alone on HIV-1 shedding and MTCT. However, observational studies indicate that low serum selenium concentrations are related to increased risks of genital mucosal shedding of HIV-1-infected cells (Baeten et al., 2001 ) and intrapartum HIV-1 transmission (Kupka et al., 2005) . It is unknown whether selenium nutritional status is associated with lower-genital tract levels of IL-1b, a cytokine marker of vaginal inflammation that promotes HIV replication (Fichorova et al., 2001) .
To gain further insights into the nature of associations between selenium status and mediators of HIV-1 transmission, we examined how plasma selenium concentrations relate to lower-genital HIV-1 shedding and concentrations of IL-1b among pregnant Tanzanian women.
Methods
Study participants were HIV-1-positive women who were part of a randomized trial that examined the effect of vitamin supplements on maternal and child health outcomes. In brief, study participants were pregnant between 12 and 27 weeks of gestation, resided in Dar es Salaam, Tanzania and received b-carotene/vitamin A, multivitamins including b-carotene/vitamin A, multivitamins without b-carotene/ vitamin A, or placebo during the antenatal and postnatal periods (Fawzi et al., 1998) . Selenium was not given as part of the study. At enrollment, sociodemographic and anthropometric data were collected. Blood samples were drawn to measure plasma concentrations of selenium, as well as other nutritional and immunologic parameters. At 36 weeks of gestation, cervicovaginal lavage (CVL) specimens were obtained from study participants to determine concentrations of HIV-1 RNA and IL-1b.
To conduct selenium analyses, duplicate samples were prepared from plasma samples to measure both selenium and sodium using neutron activation analysis (Mason et al., 1998) . The selenium concentration was adjusted for the sodium concentration of the sample, which is tightly regulated physiologically, to account for the degree of concentration or dilution of the sample. The adjustment was performed by regressing the selenium concentration of the sample onto the sample's sodium concentration and obtaining the residuals from this regression. The median selenium value was added back to the residuals to make them interpretable.
For measurement of HIV-1 RNA and IL-1b levels, normal saline (8 ml) was applied to the exterior cervical os and the pool of fluid that formed in the posterior vaginal cavity was aspirated and immediately aliquoted into two 4 ml cryovials. These aliquots were transferred to the local laboratory and stored at À701C until they were shipped to Boston, US, on liquid nitrogen for analysis. For HIV-1 RNA quantification, 250 ml of the sample supernatant was diluted to 1 ml in Trizol reagent; RNA was extracted, reverse transcribed and cDNA containing the HIV-1 sequence was amplified by polymerase chain reaction. Details of the HIV-1 RNA quantification assay have been published elsewhere (Fawzi et al., 2004a) . IL-1b concentrations in CVL samples were measured using enzyme-linked immunosorbent assays (R&D Systems, Minneapolis, MN, USA) diluted 1:2 in normal saline. Quadratic regression analysis was used to determine IL-1b concentrations on the basis of logarithmically transformed optical densities.
A CVL sample was requested from 637 of the 1078 women enrolled in the original trial (Fawzi et al., 2004a) . Of those, 409 women provided a specimen, 393 had adequate specimens to determine both HIV-1 and IL-1b levels and 340 women also had valid baseline selenium measurements. These women constitute the analysis cohort. In previous work (Kupka et al., 2005) , we examined the association between selenium concentrations and MTCT of HIV-1. For such analyses, 670 women (and their infants) from the original trial were eligible, and selenium concentrations were classified as tertiles. The present analysis cohort is a subset of these 670 women. To facilitate comparisons between studies, we adopted cutoff levels from previous work, which were (in mg/l) o114, 114-131 and 4131 for the lowest, middle and highest tertiles, respectively. Tests for trend were constructed using an ordinal variable that represented the median selenium concentration of each tertile.
We used binomial regression models with a natural logarithm link function to assess the association between selenium concentrations and risk of HIV-1 shedding, defined as detectable levels of HIV-1 RNA versus non-detectable levels. Mixed regression models with an empirical variance estimator and the maximum likelihood function were used to model levels of HIV-1 RNA (log 10 -transformed) and IL-1b.
Potential confounding variables were identified based on prior knowledge and scientific plausibility. These variables included plasma HIV-1 RNA (available on N ¼ 89 at enrollment) as well as various nutritional, immunological, socioeconomic, demographic, anthropometric and gynecological parameters. Variables that altered the effect estimates for the selenium terms by X10% in binomial (for risk of HIV-1 shedding) and mixed regression models (for continuous levels of IL-1b and log 10 transformed HIV-1 RNA) were entered and retained in multivariate models. As b-carotene/ vitamin A supplements increased the risk of genital HIV-1 shedding in the parent trial (Fawzi et al., 2004a) , all multivariate regression models included a term for b-carotene/vitamin A supplementation. Effect modification by b-carotene/vitamin A was assessed using the likelihood ratio test in binomial regression models and the Wald w 2 -test in mixed regression models. The missing indicator method was used for covariates with missing values to prevent observations being eliminated from multivariate models (Miettinen, 1985) .
As genital tract infections may override effects that may be due to selenium deficiency (Baeten et al., 2001) , additional analyses were conducted that excluded 123 women with such infections. The following conditions were considered, with the number of women with condition listed in parentheses (some women suffered from 41 condition): Mean differences (in log 10 -transformed HIV-1 RNA/ml) obtained from multivariate mixed regression models with an empirical variance estimator. Adjusted for vitamin A regimen group and baseline values of CD4 cell count (o, X350/mm 3 ), viral load (o, X50 000 copies/ml), erythrocyte sedimentation rate (o, X81 mm/ h), hemoglobin (o, X8.5 g/dl), plasma vitamin A (o, X20 mg/dl), mid-upper arm circumference (o, X27 cm) and amount of average household income (in Tanzanian Shillings (TSh)) spent on food per household member per day (o,X500 TSh). d Log 10 -transformed HIV-1 RNA/ml. e Mean differences (in mg/ml) obtained from multivariate mixed regression models with an empirical variance estimator. Adjusted for vitamin A regimen group and baseline values of erythrocyte sedimentation rate (o, X81 mm/h), hemoglobin (o, X8.5 g/dl), syphilis infection and educational status (o, X5 years of schooling). f mg/ml.
In multivariate binomial regression models, women in the middle tertile had a significantly increased risk of viral shedding (relative risk (RR) ¼ 1.21, 95% CI ¼ 1.02, 1.44), whereas the risk was marginally elevated for women in the highest tertile (RR ¼ 1.16, 95% CI ¼ 0.97, 1.39), compared to women in the lowest tertile (Table 1) . Similarly, HIV-1 RNA levels were elevated significantly in the middle tertile (difference ¼ 0.30 log 10 /ml, 95% CI ¼ 0.10, 0.50) and nonsignificantly (difference ¼ 0.17 log 10 /ml, 95% CI ¼ À0.03, 0.36) in the highest tertile. Mean IL-1b concentrations among women with intermediate (difference ¼ À23 mg/ml, 95% CI ¼ À329, 282) and highest (difference ¼ À178 mg/ml, 95% CI ¼ À416, 59) concentrations of plasma selenium were not significantly different from means among women with lowest plasma selenium concentrations.
Excluding women with genital tract infections at baseline (N ¼ 123) strengthened the associations for risk of HIV-1 shedding (Table 2 ). Women in the middle and highest tertiles had significantly increased risk of HIV-1 shedding (RR ¼ 1.46, 95% CI ¼ 1.10, 1.92 and RR ¼ 1.39, 95% CI ¼ 1.05, 1.84, respectively) in reference to the lowest tertile. HIV-1 RNA levels were nonsignificantly elevated by 0.20 log 10 /ml for both middle and highest tertiles in comparison to the lowest, although there was no evidence for an association between tertiles of plasma selenium and levels of IL-1b.
There was evidence that supplements containing b-carotene and vitamin A, which were predictive of an increased risk of HIV-1 shedding in this cohort (Fawzi et al., 2004a) , modified the association between plasma selenium concentrations and risk of HIV-1 shedding. Among women who received b-carotene/vitamin A, the risks for HIV-1 shedding were significantly elevated among the middle and highest tertiles (RR ¼ 
Discussion
In this study among HIV-1-infected pregnant women, plasma selenium concentrations X114 mg/l were associated with an increased risk of HIV-1 shedding in CVL specimens, Mean differences (in log 10 -transformed HIV-1 RNA/ml) obtained from multivariate mixed regression models with an empirical variance estimator. Adjusted for vitamin A regimen group and baseline values of CD4 cell count (o, X350/mm 3 ), viral load (o, X50 000 copies/ml), erythrocyte sedimentation rate (o, X81 mm/h), hemoglobin (o, X8.5 g/dl), plasma vitamin A (o, X20 mg/dl), mid-upper arm circumference (o, X27 cm) and amount of average household income (in Tanzanian Shillings (TSh)) spent on food per household member per day (o, X500 TSh). d Log 10 -transformed HIV-1 RNA/ml. e Mean differences (in mg/ml) obtained from multivariate mixed regression models with an empirical variance estimator. Adjusted for vitamin A regimen group and baseline values of erythrocyte sedimentation rate (o, X81 mm/h), hemoglobin (o, X8.5 g/dl) and educational status (o, X5 years of schooling). f mg/ml. especially among women who did not suffer from genital tract infections at baseline. Although there was some indication that plasma selenium concentrations X114 mg/l were related to increased HIV-1 RNA levels, they were not related to IL-1b concentrations.
The association between plasma selenium concentrations and risk of viral shedding apparently disagrees with the inverse association between selenium concentrations and intrapartum MTCT of HIV-1 previously reported from this cohort (Kupka et al., 2005) . We formerly hypothesized that the increased risk of MTCT of HIV-1 among women with low plasma selenium concentrations was mediated by increased viral shedding; however, our current findings do not support this hypothesis.
The positive association between selenium concentrations and risk of viral shedding also contrasts with the findings from a study on Kenyan women who did not have evidence of locally acting determinants of genital HIV-1 shedding, such as presence of genital tract infections or use of oral contraceptives or depot medroxyprogesterone acetate (Baeten et al., 2001) . In that study, selenium deficiency (defined as o85 mg/l) was associated with an elevated risk of genital mucosal shedding of HIV-1-infected cells. Only three out of the 340 participants had plasma selenium levels o85 mg/l in the present cohort, so that this cutoff could not be used in analyses. In addition to the difference in exposure classification, clients in the Kenyan study were not pregnant and the hormonal changes associated with the state of pregnancy may have modified the association between selenium concentrations and genital HIV shedding. Different sample collection techniques may have also contributed to the differences in findings. In the Kenyan study, vaginal and cervical swab samples were used and HIV-1 DNA was measured, whereas CVL samples were used in the present study and cell-free HIV-1 RNA was measured (Baeten et al., 2001) . Both HIV-1 RNA and DNA levels in genital tract samples have been associated with HIV-1 MTCT, suggesting that both infected cells and cell-free virus may play a role in perinatal HIV-1 transmission (Montano et al., 2003; Tuomala et al., 2003) .
However, our observational findings on the association between plasma selenium concentrations and risk of viral shedding are in line with the hypothesis that selenium supplements may increase the risk of viral shedding, which is based on data from two African randomized, controlled trials. In the first trial, conducted in Kenya, supplements containing vitamins B, C and E and selenium increased the risk of detecting HIV-1 DNA and RNA in vaginal swab samples . In a second trial, conducted in Tanzania, supplements containing vitamins B, C and E at identical dosages, but without selenium, did not lead to increased detection of HIV-1 RNA in CVL samples (Fawzi et al., 2004a) . This raises the possibility that the selenium component may have accounted for the adverse effect, which is also supported by the fact that adverse effect in the Kenyan study was most pronounced among women with adequate selenium concentrations (defined as X85 mg/l) .
In the present study, both HIV-1 RNA levels and risk of viral shedding were elevated in tertiles defined by plasma selenium concentrations of 114-131 and 4131 mg/l, suggesting that concentrations X114 mg/l may represent a threshold. There is uncertainty about optimal plasma selenium levels, given that different selenoproteins are optimally expressed at different plasma concentrations (Rayman, 2002) . Activity of glutathione peroxidase, an important antioxidant enzyme system in the body, plateaus when plasma concentrations are in the range of 95-135 mg/l (Neve, 2000) . Given that HIV disease is associated with high amounts of oxidative stress (Pace and Leaf, 1995) , optimal expression of glutathione peroxidase appears beneficial. However, high activity of the enzyme may in fact be harmful during the early phase of the HIV-1 life cycle (Diamond et al., 2001) , which may help explain the increased viral load and increased risk of viral shedding observed among participants with selenium concentrations X114 mg/l.
Supplements containing b-carotene and vitamin A were shown to increase the risk of lower genital shedding of HIV-1 in this cohort (Fawzi et al., 2004a) . We found evidence that the potential adverse effect of high selenium levels was limited to women receiving supplements containing b-carotene and vitamin A. Vitamin A may lead to increased replication of HIV-1 in vitro (Kitano et al., 1990; Turpin et al., 1992) and may increase the number of infected cells by promoting the differentiation of myeloid and lymphoid cells (MacDonald et al., 2001) . b-Carotene exhibits antioxidant, but under certain circumstances also pro-oxidant effects (Burton and Ingold, 1984) , and may thus be relevant for mechanisms that regulate HIV replication via oxidative stress. Even though our findings suggest that selenium may engage in a biologic synergism with vitamin A and b-carotene that may be detrimental for risk of viral shedding, the exact mechanisms remain to be elucidated.
It is a limitation of this observational study that data on potentially important covariates such as plasma albumin, a selenium transport protein (Deagan et al., 1993) that has been associated with adverse HIV-1-related end points (Feldman et al., 2000 (Feldman et al., , 2003 , were not available. Secondly, analyses may have been confounded because the underlying immune impairments and inflammation may have depressed selenium levels (Drain et al., 2006) . However, as the study population was largely asymptomatic at enrollment and because we adjusted for important proxies of immune function, this bias is unlikely to be large. Lastly, it is a design limitation that plasma selenium concentrations were not measured at the same time point as the outcome variables.
In summary, this study describes complex associations between selenium status and HIV-1 transmission-related end points, with a potential adverse effect of plasma selenium concentrations X114 mg/l for HIV-1 shedding in the female lower genital tract. More insights from observational studies would be useful but, more importantly, the results of selenium supplementation trials are awaited to clarify the role of selenium status for end points related to HIV-1 transmission.
